Johnson, J A <br/><br/>
Clopidogrel: a case for indication-specific pharmacogenetics.  [electronic resource] 

 -  Clinical pharmacology and therapeutics  May 2012 
 - 774-6 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1532-6535 
<br/><br/><label>Standard No.: </label>10.1038/clpt.2012.21  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Clopidogrel<br/>Cytochrome P-450 CYP2C19<br/>Genotype<br/>Humans<br/>Pharmacogenetics<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Ticlopidine--adverse effects